Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
GYRE holding history
Gyre Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GYRE overviewAll 13F holders of GYREFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −13,900−100.0% | Sold out | Holders |
| Q2 2024 | 13,900 | $165.8K | <0.1% | +13,900 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −17,085−100.0% | Sold out | Holders |
| Q4 2023 | 17,085 | $439.0K | <0.1% | −573,602−97.1% | Reduced | Holders |
| Q3 2023 | 590,687 | $285.0K | <0.1% | −183,699−23.7% | Reduced | Holders |
| Q2 2023 | 774,386 | $272.0K | <0.1% | −101,500−11.6% | Reduced | Holders |
| Q1 2023 | 875,886 | $181.0K | <0.1% | −311,100−26.2% | Reduced | Holders |
| Q4 2022 | 1,186,986 | $626.0K | <0.1% | +85,716+7.8% | Added | Holders |
| Q3 2022 | 1,101,270 | $555.0K | <0.1% | +304,284+38.2% | Added | Holders |
| Q2 2022 | 796,986 | $1.42M | <0.1% | −372,876−31.9% | Reduced | Holders |
| Q1 2022 | 1,169,862 | $772.0K | <0.1% | −602,046−34.0% | Reduced | Holders |
| Q4 2021 | 1,771,908 | $1.62M | <0.1% | +1,732,123+4,353.7% | Added | Holders |
| Q3 2021 | 39,785 | $164.0K | <0.1% | −408,412−91.1% | Reduced | Holders |
| Q2 2021 | 448,197 | $1.94M | <0.1% | +448,197 | New | Holders |